MoneyWorks4Me

Astrazeneca Pharma I - Quaterly Results

08 Aug 2024 Evaluate
The sales moved up 31.15% to Rs. 3875.20 millions for the June 2024 quarter as compared to Rs. 2954.70 millions during the year-ago period.The Net Loss for the quarter ended June 2024 is Rs. -117.90 millions as compared to Net Profit of Rs. 538.60 millions of corresponding quarter ended June 2023A decline of 464.20 millions was observed in the OP in the quarter ended June 2024 from 753.40 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 3875.20 2954.70 31.15 3875.20 2954.70 31.15 12955.28 10029.71 29.17
Other Income 83.50 81.00 3.09 83.50 81.00 3.09 348.00 261.02 33.32
PBIDT 464.20 753.40 -38.39 464.20 753.40 -38.39 2192.52 1912.27 14.66
Interest 1.10 1.50 -26.67 1.10 1.50 -26.67 12.01 6.33 89.73
PBDT -112.50 751.90 -114.96 -112.50 751.90 -114.96 2344.77 1503.65 55.94
Depreciation 39.10 37.90 3.17 39.10 37.90 3.17 149.40 162.60 -8.12
PBT -151.60 714.00 -121.23 -151.60 714.00 -121.23 2195.37 1341.05 63.71
TAX -33.70 175.40 -119.21 -33.70 175.40 -119.21 580.28 348.12 66.69
Deferred Tax -141.20 0.70 -20271.43 -141.20 0.70 -20271.43 -9.03 -34.90 -74.13
PAT -117.90 538.60 -121.89 -117.90 538.60 -121.89 1615.09 992.93 62.66
Equity 50.00 50.00 0.00 50.00 50.00 0.00 50.00 50.00 0.00
PBIDTM(%) 11.98 25.50 -53.02 11.98 25.50 -53.02 16.92 19.07 -11.24
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..